Ensign Peak Advisors
SKYE icon

Ensign Peak Advisors’s Skye Bioscience SKYE Stock Holding History

Ensign Peak Advisors’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-767,287
Closed -$3.02M – 1736
2025
Q3 		$3.02M Hold
767,287
– – ﹤0.01% 706
2025
Q2 		$3.21M Hold
767,287
– – 0.01% 745
2025
Q1 		$1.22M Hold
767,287
– – ﹤0.01% 1136
2024
Q4 		$2.17M Sell
767,287
-132,713
-15% -$555K ﹤0.01% 902
2024
Q3 		$3.52M Buy
+900,000
New +$5.05M 0.01% 746

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return